This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sariban-Sohraby, S. Articles by Balaban, R. S. Search for Related Content PubMed PubMed Citation Articles by Sariban-Sohraby, S. Articles by Balaban, R. S.

Comparison of Energy Metabolism in Human Normal and Neoplastic (Burkitt's Lymphoma) Lymphoid Cells

Laboratory of Kidney and Electrolyte Metabolism, National Heart, Lung, and Blood Institute [S. S-S., R. S. B.], and Pediatric Oncology Branch [I. T. M.], National Cancer Institute, NIH, Bethesda, Maryland 20205

In order to detect possible differences in the energy metabolism between normal and neoplastic lymphoid cells, we studied purified normal human lymphocytes (FL) and transformed lymphoblastoid cell lines derived from umbilical cord blood (CL) and compared them to cell lines derived from American Burkitt's lymphoma (BL). The total adenosine triphosphate production rate by these cells was estimated by measuring O₂ consumption and lactic acid production rates. O₂ consumption (nmol/min/mg protein) was 4.9 ± 0.3 (S.D.) in CL, 4.4 ± 0.3 in FL, and 4.9 ± 0.3 in BL. Lactic acid production (nmol/min/mg protein) was 30.9 ± 3.0 in CL, 29.9 ± 3.0 in FL, and 23.4 ± 4.0 in BL. Using these values of O₂ consumption and lactic acid production, the average adenosine triphosphate production rates (nmol/min/mg protein) were calculated to be 60 in CL, 56 in FL, and 53 in BL. We conclude that the BL do not have more aerobic glycolysis than do normal lymphoid cells, suggesting that the lactic acidosis seen in American Burkitt's lymphoma is not due to a preferential glycolytic metabolism of the tumor. More likely, the lactic acidosis is simply due to the large total mass of these neoplastic cells and not due to a modification of their energy metabolism.

¹ A USPHS international research fellow (5 F05 TWO 02961-02).

Received 3/31/83. Accepted 7/11/83.

This article has been cited by other articles:

				S. M. Schieke, D. Phillips, J. P. McCoy Jr., A. M. Aponte, R.-F. Shen, R. S. Balaban, and T. Finkel The Mammalian Target of Rapamycin (mTOR) Pathway Regulates Mitochondrial Oxygen Consumption and Oxidative Capacity J. Biol. Chem., September 15, 2006; 281(37): 27643 - 27652. [Abstract] [Full Text] [PDF]

				S. Matoba, J.-G. Kang, W. D. Patino, A. Wragg, M. Boehm, O. Gavrilova, P. J. Hurley, F. Bunz, and P. M. Hwang p53 Regulates Mitochondrial Respiration Science, June 16, 2006; 312(5780): 1650 - 1653. [Abstract] [Full Text] [PDF]

				S. Nemoto, C. A. Combs, S. French, B.-H. Ahn, M. M. Fergusson, R. S. Balaban, and T. Finkel The Mammalian Longevity-associated Gene Product p66shc Regulates Mitochondrial Metabolism J. Biol. Chem., April 14, 2006; 281(15): 10555 - 10560. [Abstract] [Full Text] [PDF]

				W. K. Chau, C. F. Yang, Y. H. Chou, and C. H. Ho Aggressive Undifferentiated Carcinoma of Unknown Primary Site Complicated by Lactic Acidosis After Bleeding: a Case Report Jpn. J. Clin. Oncol., June 1, 2002; 32(6): 210 - 214. [Abstract] [Full Text] [PDF]

				D. E. Epner, A. Sawa, and J. T. Isaacs Glyceraldehyde-3-Phosphate Dehydrogenase Expression During Apoptosis and Proliferation of Rat Ventral Prostate Biol Reprod, September 1, 1999; 61(3): 687 - 691. [Abstract] [Full Text]